Predictors of chemotherapy efficacy in non|small|cell lung cancer

Predictors of chemotherapy efficacy in non-small-cell lung cancer

The search for predictive biomarkers to CCC has been proven challenging. If a plethora of biomarkers have been evaluated either in the preclinical or in the ...

Predictors of chemotherapy efficacy in non-small-cell lung cancer

Results. The best-validated predictive biomarkers for efficacy are currently ERCC1, RRM1, and TS for platinum agents, gemcitabine and pemetrexed, respectively.

Predictors of chemotherapy efficacy in non-small-cell lung cancer

The best-validated predictive biomarkers for efficacy are currently ERCC1, RRM1, and TS for platinum agents, gemcitabine and pemetrexed, respectively.

Blood biomarkers to predict the efficacy of neoadjuvant chemo ...

Keywords: Squamous cell carcinoma antigen (SCCA); chemo-immunotherapy; non-small cell lung cancer (NSCLC); platelet-lymphocyte ratio (PLR). 2024 ...

Predictors of chemotherapy efficacy in non-small-cell lung cancer

CCC, conventional cytotoxic chemotherapy; NSCLC, non-small-cell lung cancer; AICART, aminoimidazolecarboxamide ribonucleotide formyltransferase; ...

Is there room for further improvement? - ASCO Publications

Comprehensive analysis of predictive factors for efficacy in concurrent chemo-radiotherapy for locally advanced non-small cell lung cancer, utilizing individual ...

Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung ...

Abstract. Purpose: No validated biomarkers that could identify the subset of patients with lung adenocarcinoma who might benefit from chemotherapy have.

Blood biomarkers to predict the efficacy of neoadjuvant chemo ...

Lung cancer is one of the most prevalent and deadly cancers worldwide, with non-small cell lung cancer (NSCLC) accounting for approximately 80– ...

Predictors of Survival in Patients With Non-Small Cell Lung Cancer

Conclusions: This study detected two known clinical parameters, cancer stage and nutritional status (i.e., BMI and neutrophil and platelet counts), as having ...

[PDF] Predictors of chemotherapy efficacy in non-small-cell lung ...

The search for predictive biomarkers to CCC has been proven challenging and if a plethora of biomarkers have been evaluated either in the preclinical or in ...

Efficacy and clinicogenomic correlates of response to immune ...

The role of combination chemotherapy with immune checkpoint inhibitors (ICI) (ICI-chemo) over ICI monotherapy (ICI-mono) in non-small cell ...

Advances in efficacy prediction and monitoring of neoadjuvant ...

Recently, several prognostic and predictive factors associated with the efficacy of neoadjuvant immunotherapy in NSCLC, such as tumor-intrinsic biomarkers, ...

Features of Potentially Predictive Biomarkers of Chemotherapeutic ...

One-size-fits-all chemotherapy does not improve survival in patients with small cell lung cancer (SCLC). Excision repair cross-complementing group 1 (ERCC1) ...

Curative efficacy might be an early predictor of prognosis in patients ...

Background: Platinum-based chemotherapy remains the essential therapy for small cell lung cancer (SCLC). Here, we conducted a statistical analysis to explore ...

Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo ...

Chemo-radiotherapy (CRT) remains the main treatment modality for non-small-cell lung cancer (NSCLC). However, its clinical efficacy is ...

Efficacy outcomes and prognostic factors from real-world patients ...

Treatment of advanced non-small cell lung cancer (aNSCLC) has moved into an entirely new era thanks to the targeted and immunological therapies [1], [2]. The ...

Machine Learning for Prediction of Immunotherapy Efficacy in Non ...

We studied determinants of response to immune-checkpoint inhibition in advanced non-small cell lung cancer patients. Specifically, we evaluated the ...

Meta-analysis of the efficacy of postoperative adjuvant... - Medicine

Zhou K, Zhao Y, Liang L, et al. Adjuvant chemotherapy may improve long-term outcomes in stage IB non-small cell lung cancer patients with ...

Clinical predictors of response to single‑agent immune checkpoint ...

Single‑agent immune checkpoint inhibitors (ICIs) are the standard option for chemotherapy‑pretreated metastatic non‑small cell lung cancer ...

Predictors of chemotherapy efficacy in Non-Small Cell Lung Cancer ...

Background Conventional cytotoxic chemotherapy (CCC) is the backbone of non-small cell lung cancer (NSCLC) treatment since decades, and still represents a ...